Dong-A breaking through the patent wall of Baraclude

Last July, Dong-A ST has rapidly launched ‘Baracle Tab,’ a generic of Baraclude which left a month to its patent expiration. Its strategy is to preoccupy the market by breaking through the patent wall.

‘Baraclude,’ a hepatitis B treatment worth of KRW 200 billion annual sales, is going to be expired in substance patent on the coming September. Thus, a number of domestic pharmaceutical companie...